We are live on ! Find out more
PNAA

Pictet North America Advisors Portfolio holdings

AUM $1.13B
1-Year Est. Return 17.98%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+17.98%
3 Year Est. Return
+65.91%
5 Year Est. Return
+71.69%
10 Year Est. Return
+291.08%
AUM
$632M
AUM Growth
+$29.9M
Cap. Flow
-$5.92M
Cap. Flow %
-0.94%
Top 10 Hldgs %
47.42%
Holding
136
New
6
Increased
21
Reduced
50
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 11.99%
2 Financials 10.18%
3 Communication Services 8.85%
4 Healthcare 4%
5 Consumer Discretionary 2.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLNX
126
DELISTED
Xilinx Inc
XLNX
$207K 0.03%
+2,922
New +$191K
TSM icon
127
TSMC
TSM
$2.19T
$190K 0.03%
26,682
HSBC icon
128
HSBC
HSBC
$354B
$186K 0.03%
20,575
BP icon
129
BP
BP
$109B
$143K 0.02%
24,728
-426
-2% -$13.5K
TTM
130
DELISTED
Tata Motors Limited
TTM
$77K 0.01%
12,515
+250
+2% +$8.04K
GE icon
131
GE Aerospace
GE
$383B
-14,204
Closed -$1.84M
NWL icon
132
Newell Brands
NWL
$2.5B
-3,836
Closed -$206K
TAP icon
133
Molson Coors Class B
TAP
$7.81B
-9,360
Closed -$808K
VOO icon
134
Vanguard S&P 500 ETF
VOO
$1.03T
-1,200
Closed -$266K
XOM icon
135
ExxonMobil
XOM
$654B
-12,800
Closed -$1.03M
VXX
136
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
-164,442
Closed -$8.39M

Similar funds

Pictet North America Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Pictet North America Advisors held 136 positions worth $632M, up 5% from $602M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pictet North America Advisors's Q3 2017 filing shows 6 new, 21 increased, 50 reduced and 6 closed positions. Its largest new stake was Teva Pharmaceuticals: 105,149 shares worth $1.84M. The largest sale was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $8.39M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Communication Services.

  • Pictet North America Advisors's largest Q3 2017 buy was Teva Pharmaceuticals: 105,149 shares worth $1.84M.
  • Pictet North America Advisors added most to Baidu in Q3 2017, an estimated $15M increase.
  • Pictet North America Advisors's biggest Q3 2017 reduction was iShares S&P 100 ETF, cutting an estimated $2.48M.
  • Pictet North America Advisors fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q3 2017, selling an estimated $8.39M.
  • Pictet North America Advisors's ten largest holdings make up 47% of its $632M portfolio in Q3 2017.
  • Pictet North America Advisors opened 6 new positions and closed 6 in Q3 2017.
  • Pictet North America Advisors's portfolio value rose 5% quarter-over-quarter to $632M.

Based on Pictet North America Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.